Cabaletta Bio, Inc. (CABA)
2.91
-0.36
(-11.01%)
USD |
NASDAQ |
Sep 09, 16:00
2.96
+0.05
(+1.72%)
After-Hours: 04:43
Cabaletta Bio Market Cap : 488.08M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 488.08M |
| September 08, 2026 | 548.47M |
| September 04, 2026 | 582.01M |
| September 03, 2026 | 583.69M |
| September 02, 2026 | 598.78M |
| September 01, 2026 | 553.50M |
| August 31, 2026 | 521.63M |
| August 28, 2026 | 523.31M |
| August 27, 2026 | 566.92M |
| August 26, 2026 | 545.11M |
| August 25, 2026 | 540.08M |
| August 24, 2026 | 519.95M |
| August 21, 2026 | 524.98M |
| August 20, 2026 | 535.05M |
| August 19, 2026 | 519.95M |
| August 18, 2026 | 488.08M |
| August 17, 2026 | 484.73M |
| August 14, 2026 | 461.25M |
| August 13, 2026 | 454.54M |
| August 12, 2026 | 478.02M |
| August 11, 2026 | 467.96M |
| August 10, 2026 | 469.63M |
| August 07, 2026 | 310.60M |
| August 06, 2026 | 307.26M |
| August 05, 2026 | 301.69M |
| Date | Value |
|---|---|
| August 04, 2026 | 308.37M |
| August 03, 2026 | 299.46M |
| July 31, 2026 | 298.35M |
| July 30, 2026 | 302.80M |
| July 29, 2026 | 291.67M |
| July 28, 2026 | 303.92M |
| July 27, 2026 | 302.80M |
| July 24, 2026 | 299.46M |
| July 23, 2026 | 302.80M |
| July 22, 2026 | 306.14M |
| July 21, 2026 | 313.94M |
| July 20, 2026 | 306.14M |
| July 17, 2026 | 315.05M |
| July 16, 2026 | 297.24M |
| July 15, 2026 | 308.37M |
| July 14, 2026 | 297.24M |
| July 13, 2026 | 307.81M |
| July 10, 2026 | 331.19M |
| July 09, 2026 | 346.78M |
| July 08, 2026 | 348.45M |
| July 07, 2026 | 345.11M |
| July 06, 2026 | 335.09M |
| July 02, 2026 | 355.13M |
| July 01, 2026 | 332.86M |
| June 30, 2026 | 346.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 292.34M |
| Amgen, Inc. | 211.52B |
| Anika Therapeutics, Inc. | 279.44M |
| BioCryst Pharmaceuticals, Inc. | 2.248B |
| Imunon, Inc. | 7.045M |
Market Cap Related Metrics
| Price to Book Value | 2.318 |
| Price | 2.91 |
| Earnings Yield | -54.36% |